Bacterin stock will be trading on the OTCQX marketplace after the New York Stock Exchange suspended trading the company's common stock.
"Our move to the OTCQX will enable to company to continue a transparent trading and information experience for investors at a lower cost, while our management team focuses on growing the business and delivering long-term value to shareholders," said CEO Dan Goldberger.
Here are five quick facts about the switch:
• Common stock trading on NYSE was suspended, according to a NYSE Regulation staff notice.
• NYSE Regulation previously delisted the company.
• Bacterin appealed NYSE Regulation's decision to delist.
• Current financial disclosures and Real-Time Level 2 quotes for Bacterin are available to investors on OTCMarkets.com
• As of April 8, the company had a market cap of $28.07 million.